ATE242766T1 - Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen - Google Patents

Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen

Info

Publication number
ATE242766T1
ATE242766T1 AT97953948T AT97953948T ATE242766T1 AT E242766 T1 ATE242766 T1 AT E242766T1 AT 97953948 T AT97953948 T AT 97953948T AT 97953948 T AT97953948 T AT 97953948T AT E242766 T1 ATE242766 T1 AT E242766T1
Authority
AT
Austria
Prior art keywords
benzoylalkyl
tetrahydropyridines
new derivatives
compounds
formula
Prior art date
Application number
AT97953948T
Other languages
German (de)
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Alessandra Ielmini
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE242766T1 publication Critical patent/ATE242766T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT97953948T 1996-12-24 1997-12-24 Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen ATE242766T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615957A FR2757512B1 (fr) 1996-12-24 1996-12-24 Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines
PCT/FR1997/002424 WO1998028274A1 (fr) 1996-12-24 1997-12-24 Utilisation de benzoylalkyl-1,2,3,6-tetrahydropyridines

Publications (1)

Publication Number Publication Date
ATE242766T1 true ATE242766T1 (de) 2003-06-15

Family

ID=9499090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97953948T ATE242766T1 (de) 1996-12-24 1997-12-24 Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen

Country Status (14)

Country Link
US (5) US6358965B1 (no)
EP (1) EP0950053B1 (no)
JP (1) JP2001513077A (no)
AT (1) ATE242766T1 (no)
AU (1) AU5768298A (no)
BR (1) BR9714184A (no)
CA (1) CA2272453A1 (no)
DE (1) DE69722816T2 (no)
DK (1) DK0950053T3 (no)
ES (1) ES2200218T3 (no)
FR (1) FR2757512B1 (no)
NO (1) NO325140B1 (no)
PT (1) PT950053E (no)
WO (1) WO1998028274A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459146A1 (en) * 2001-08-30 2003-03-13 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
JP5856212B2 (ja) 2014-03-19 2016-02-09 ファナック株式会社 工作機械の工具に対してワークを回転可能に支持する治具及び加工システム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208118B (en) * 1989-12-01 1993-08-30 Richter Gedeon Vegyeszet Process for producing tetrahydropyridine derivatives and pharmaceutical compositions comprising such compounds
FR2662355B1 (fr) 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
WO1998028274A1 (fr) 1998-07-02
JP2001513077A (ja) 2001-08-28
US7297799B2 (en) 2007-11-20
US6936621B2 (en) 2005-08-30
BR9714184A (pt) 2000-02-29
PT950053E (pt) 2003-10-31
EP0950053A1 (fr) 1999-10-20
US20020058672A1 (en) 2002-05-16
EP0950053B1 (fr) 2003-06-11
ES2200218T3 (es) 2004-03-01
NO993126L (no) 1999-06-23
DE69722816T2 (de) 2004-05-13
DK0950053T3 (da) 2003-09-29
US20040122032A1 (en) 2004-06-24
AU5768298A (en) 1998-07-17
FR2757512A1 (fr) 1998-06-26
US20070054931A1 (en) 2007-03-08
NO325140B1 (no) 2008-02-11
DE69722816D1 (de) 2003-07-17
FR2757512B1 (fr) 1999-03-12
CA2272453A1 (fr) 1998-07-02
NO993126D0 (no) 1999-06-23
US20050222187A1 (en) 2005-10-06
US6358965B1 (en) 2002-03-19
US7151107B2 (en) 2006-12-19

Similar Documents

Publication Publication Date Title
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
ES2184960T3 (es) Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas.
BG101118A (en) Therapeutical compounds
RO115522B1 (ro) Derivaţi de indolină, procedee pentru prepararea acestora, compoziţii farmaceutice care îi conţin şi metodă de tratament
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
IL162214A (en) Pyridine derivatives and pharmaceutical compositions containing the same
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
AP9701041A0 (en) Pyridylpyrrole compounds.
DE69807587D1 (de) Quinazolin-4-on AMPA Antagonisten
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
IL115073A (en) Use of 5-substituted pyridine-and hexahydroquinoline-3-carboxylic acid derivatives for the preparation of pharmaceutical compositions for the treatment of disorders of the central nervous system some such novel compounds their preparation and pharmaceutical compositions containing them
GB9212308D0 (en) Therapeutic compositions
ATE297396T1 (de) Neue atropisomere von 2,3-disubstituierten-(5,6)- heteroarylkondensierten-pyrimidin-4-onen
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
NO20000771D0 (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
FI941911A0 (fi) Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
IL109076A0 (en) Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
ATE242766T1 (de) Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ITMI920106A1 (it) Composizioni farmaceutiche comprendenti melatonina o un suo derivato-agonista, atte al trattamento dei disordini cerebro-vascolari
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0950053

Country of ref document: EP

REN Ceased due to non-payment of the annual fee